Presently, the NLRC4 inflammasome has been implicated in one instance of MAS, known as NLRC4-MAS, where gain-of-function mutations in NLRC4 drive MAS pathogenesis (Canna et al., 2014, 2017; Chear et al., 2020). The gene discussed is NLRC4; the disease is macrophage activation syndrome.